Warning: Undefined array key "HITSTATS_API_KEY" in /var/www/html/application/config/config.php on line 107

Warning: Undefined array key "HITSTATS_SITE_IDENTIFIER" in /var/www/html/application/config/config.php on line 108
Chamberlin & Hill Regulatory News. Live CMH RNS. Regulatory News Articles for Chamberlin Plc Ord 0.1p

We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin & Hill Regulatory News (CMH)

Share Price Information for Chamberlin & Hill (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.20
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.10 (8.333%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Audited Accounts and Trading Update

16 Sep 2021 07:00

RNS Number : 9290L
Chamberlin PLC
16 September 2021
 

Chamberlin plc

(the "Company" or Group")

Publication of Audited Accounts and Trading Update

Chamberlin plc (AIM: CMH.L), the specialist castings and engineering group, provides the following update.

Summary

· Company expects to publish audited accounts in late November 2021;

 

· Revenue of £26 million and loss of not less than £4.0 million (unaudited) for the 14 month period ended 31 May 2021 in line with management's expectations; and

· Encouraging start to current financial year; leading to expectation of stronger levels of sales growth and return to profitability in second half of year.

2021 Accounts

The COVID-19 pandemic has significantly impacted the availability of sufficient resources to support the audit timetable, compounded further by the change in the auditor and a new management team, following the re-structuring of the Company. Further to the announcement dated 14 May 2021, the Company now expects to publish its audited accounts for the 14 month period ended 31 May 2021 ("2021 Accounts"), in late November 2021.

The Board has previously indicated that the outturn for the period to 31 May 2021 will show a loss and the Board expects this to be not less than £4.0 million, on turnover for the period of £26 million, including sales of £7.5 million to BorgWarner (unaudited) (prior to loss of the BorgWarner contract). This loss contains the majority of the restructuring and rationalisation costs necessary to stabilise the Group for the future.

Current Trading

The Board is pleased to report the following trading update. The current financial year has started well with Group sales for the first quarter in line with management's expectations. Net debt at 31 August 2021, including asset leases of £1.9 million, was reduced to £3.0 million (unaudited) (30 September 2020: £4.6 million) and current cash headroom is comfortably in line with management expectations at £1.1 million. The Company has commenced a review of the use of its substantial property assets with the objective of strengthening the balance sheet and improving operational and investment returns from Group resources.

The Board expects sales for the remainder of the first half of the current financial year ending 30 November 2021, to be at least in line with management's expectations but now anticipate stronger levels of sales growth and profitability in the second half of the year resulting in an expected earnings per share for the current financial year ending 31 May 2022 of not less than 1p.

The COVID-19 pandemic continues to present global challenges to trading conditions, including escalating raw material costs, supply chain shortages and a slowdown in the automotive industry due to widely publicised electronic control unit (ECU) availability. In response to these challenges, the management team continues to reduce costs, improve efficiencies, and optimise pricing to improve margins and restore sustainable profitability to the Group.

The new Board has implemented a strategy to adapt to these changing conditions and the Company is directing resources to new product lines to rapidly reduce reliance on the automotive industry. The Board's aim over the medium term is to replace the majority of the Group's traditional, low margin contract-based production, with much higher margin, premium consumer products in markets with a strong opportunity for growth and where the Group can innovate, control distribution and sales to effect real and sustainable growth in revenue and profits.

Launch of "Emba" brand

The Company is making excellent progress with the development of its premium quality cast iron cookware - the Emba Cookware Range and expects to officially launch its initial product range on-line in November 2021. The rising popularity for premium quality, high value cast iron cookware is growing rapidly in the UK and the Board expects Chamberlin's Emba brand to be at the forefront of this market as the only true UK based designer and manufacturer.

Iron Foundry Weights

 

Iron Foundry Weights, Chamberlin's new trading name for its specialist home and commercial gym equipment business, is developing rapidly. October 2021 will see the release of its new range of precision machined "indestructible" dumbbells, with our unique "Shrink-Fit" assembly technology. The Company has recently signed an endorsement agreement with Lauren Recci, British Powerlifting Champion, and the Company will be show casing its new product range at The Arnold Sports Festival 2021.

 

Petrel

Petrel, Chamberlin's specialist lighting business, is trading profitably and exceeding the Board's expectations with a very strong start to the year. Petrel's performance in the second half of the year will be improved further by the commencement of a new venture into specialist lighting hire, which will commence next month. Petrel will be the only UK manufacturer of hazardous/harsh area lighting to offer a direct-to-market hire service when it launches in October 2021.

Russell Ductile Castings

The Company's Scunthorpe foundry operation continues to operate at, or near, full production levels in response to growing customer demand. Costs are being managed closely and operating profit is expected to exceed management expectations for the quarter ended 31 August 2021.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

Enquiries:

Chamberlin plc

Kevin Price, Chief Executive

Alan Tomlinson, Finance Director

 

 

T: 01922 707100

Cenkos Securities plc

(Nominated Adviser and Joint Broker)

Katy Birkin

Stephen Keys

 

 

T: 020 7397 8900

Peterhouse Capital Limited

(Joint Broker)

Lucy Williams

Duncan Vasey

 

T: 020 7469 0930

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFEIAIIELIL
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.